NovaBay Pharmaceuticals, Inc. (NBY)
0.7373
-0.02
(-3.00%)
USD |
NYAM |
Feb 09, 16:00
0.79
+0.05
(+7.15%)
After-Hours: 05:19
NovaBay Pharmaceuticals EPS Diluted (Quarterly) : -0.22 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cassava Sciences, Inc. | -0.2237 |
| cbdMD, Inc. | -0.0762 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.333M |
| Revenue (Quarterly) | 0.521M |
| Total Expenses (Quarterly) | 1.854M |
| Enterprise Value | 96.01M |
| Gross Profit Margin (Quarterly) | 8.06% |
| Profit Margin (Quarterly) | -255.9% |
| Earnings Yield | 80.74% |
| Normalized Earnings Yield | 91.12 |